Vanguard Group Inc Fusion Pharmaceuticals Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Fusion Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 33,036 shares of FUSN stock, worth $710,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,036Holding current value
$710,934% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FUSN
# of Institutions
142Shares Held
67.3MCall Options Held
1.36MPut Options Held
3.97M-
Federated Hermes, Inc. Pittsburgh, PA10.8MShares$233 Million0.54% of portfolio
-
Perceptive Advisors LLC New York, NY6.83MShares$147 Million3.05% of portfolio
-
Avidity Partners Management LP Dallas, TX6.5MShares$140 Million5.35% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.4MShares$138 Million2.82% of portfolio
-
Fil LTD Hamilton, D04.19MShares$90.1 Million0.09% of portfolio
About Fusion Pharmaceuticals Inc.
- Ticker FUSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,390,500
- Market Cap $934M
- Description
- Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...